BioCentury | Jun 20, 2018
Distillery Techniques

Biomarkers

TECHNOLOGY: Plasma markers Levels of miR-301a in serum-derived exosomes could help diagnose and predict progression in pancreatic cancer. In serum-derived exosomes from 50 patients, miR-301a levels were higher than in serum-derived exosomes from 12 healthy...
BioCentury | Feb 28, 2017
Distillery Therapeutics

Infectious disease

INDICATION: Encephalitis Cell culture and mouse studies suggest inhibiting miR-301a could help treat Japanese encephalitis (JE). In a mouse hippocampal cell line infected with JE virus, knockdown of miR-301a decreased viral replication compared with normal...
BioCentury | Sep 1, 2016
Distillery Therapeutics

Therapeutics: MicroRNA-301b (miR-301b); interleukin-4 (IL-4) (BSF1); transforming growth factor β 1 (TGFβ1)

...bacterial infection; Pseudomonas; Streptococcus Cell culture and mouse studies suggest that inhibiting the expression of miR-301b...
...and other Gram-negative bacterial infections. In lipopolysaccharide (LPS)-pretreated mouse alveolar macrophages or epithelial cells, a miR-301b...
...with no treatment. Next steps could include testing miR-301b inhibitors in models of sepsis. TARGET/MARKER/PATHWAY: MicroRNA-301b (miR-301b)...
BioCentury | Dec 17, 2015
Distillery Therapeutics

Therapeutics: MicroRNA-130 (miR-130); miR-301

Cardiovascular disease INDICATION: Hypertension In vitro and rodent studies suggest inhibiting the miR-130 / miR-301 family of miRNAs could help treat pulmonary arterial hypertension (PAH). miR-130a expression was higher in lungs from a rat model...
BioCentury | Jul 31, 2014
Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Hypertension MicroRNA-130 (miR-130); miR-301 Studies in human samples and mice suggest inhibiting miR-130- and miR-301-family miRNAs could help treat pulmonary hypertension (PH). In lung...
BioCentury | May 10, 2012
Distillery Therapeutics

Indication: Autoimmune disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Multiple sclerosis (MS) MicroRNA-301a (miR-301a) A study in mice suggests antagonizing miR-301a could help treat MS. In an experimental autoimmune encephalomyelitis (EAE) mouse model...
BioCentury | Jan 6, 2011
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Pancreatic cancer MicroRNA-301a (miR-301a); NF-kB In vitro and mouse studies suggest that inhibiting miR-301a could help treat pancreatic cancer. In vitro, miR-301a activated expression of...
Items per page:
1 - 7 of 7